
Life sciences equity analyst with a passion for biotech and healthcare investing. Founder of NDF Research and co-founder of Pitt Street Research, known for turning complex science and technology into clear, investable ideas
https://pittstreetresearch.com/Key Takeaways Unicycive has completed clinical development of its lead asset, Oxylanthanum Carbonate (OLC). OLC is designed to improve on current phosphate binders by offering better efficacy, fewer pills, and improved tolerability for dialysis patients with hyperphosphatemia.Read more
